Navigation Links
ProUroCare Medical Inc. Announces Completion of Warrant Replacement Offering
Date:8/5/2010

EDEN PRAIRIE, Minn., Aug. 5 /PRNewswire-FirstCall/ -- ProUroCare Medical Inc. (OTC Bulletin Board: PUMD) today announced the successful completion of its tender offer to holders of certain outstanding warrants, resulting in the exercise of warrants to purchase approximately 1 million shares of common stock.  Under the offer, the terms of the warrants were temporarily modified so that holders who exercised their warrants by August 2, 2010 would receive, in addition to the shares of common stock purchased upon exercise, an equal number of three-year replacement warrants.  The replacement warrants are exercisable at $1.30 per share and may be called at ProUroCare's discretion at any time after the last sales price of its common stock equals or exceeds $4.00 per share for ten consecutive trading days.

Holders of $1.05 million of the company's debt paid for the warrant exercise by cancelling their promissory notes.  Warrants to purchase 198,312 shares of common stock were exercised for cash, resulting in gross proceeds to the company of approximately $258,000.  Cash proceeds from the offering are to be used to obtain market clearance of the ProUroScan™ system, fund manufacturing and market scale-up activities, expand intellectual property rights, form a scientific advisory panel and conduct clinical studies and for other general corporate purposes.

About ProUroCare Medical Inc.

ProUroCare Medical Inc. is a publicly traded company engaged in the business of developing innovative medical imaging products. The company's current focus is the ProUroScan prostate imaging system, which is used to document abnormalities of the prostate detected by a Digital Rectal Exam (DRE).  Based in Minneapolis, Minn., ProUroCare is quoted on the OTCBB.

Safe Harbor Statement

This news release contains certain "forward-looking" statements. These statements are typically preceded by words such as "believes," "expects," "anticipates," "intends," "will," "may," "should," or similar expressions. These forward-looking statements are not guarantees of ProUroCare's future performance and involve a number of risks and uncertainties that may cause actual results to differ materially from the results discussed in these statements. Factors that might cause ProUroCare's results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, the ability of ProUroCare to find adequate financing to complete the development of its products; the high level of secured and unsecured debt incurred by ProUroCare; the dependence by ProUroCare on third parties for the development and manufacture of its products; and other risks and uncertainties detailed from time to time in ProUroCare's filings with the Securities and Exchange Commission including its most recently filed Form 10-K and Form 10-Q. ProUroCare undertakes no duty to update any of these forward-looking statements.


'/>"/>
SOURCE ProUroCare Medical Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ProUroCare Medical Announces Offering of Replacement Warrants in Exchange for Early Exercise of Outstanding Warrants
2. ProUroCare Medical Secures $885,000 in Financing
3. ProUroCare to Showcase Investigational Portable Platform for Its Prostate Imaging Device at AUA 2010
4. ProUroCare Medical Announces Filing of Request to Classify the Prostate Mechanical Imager ("PMI") as a Class II Device
5. ProUroCare Medical Elects Two New Directors
6. ProUroCare Medical Completes Multiple Site Clinical Study for Imaging Prostate Abnormalities
7. ProUroCare Medical Completes Clinical Trial at Second Study Site Using Digital Prostate Imaging Technology
8. ProUroCare Medical Inc. Announces Pricing of Equity Offering
9. Invivo Wins Medical Design Excellence Award for Prostate Solutions
10. Concord Medical to Report Second Quarter 2010 Financial Results on Wednesday, August 18, 2010
11. Water Street Healthcare Partners Announces New Investment in Medical Specialties Distributors, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... March 22, 2017 AMRI , a ... been working with the life sciences industry to improve ... 25 years, has been recognized for its excellence as ... as part of the Life Science Leader,s 2017 ... expertise, quality and reliability. "Competing with ...
(Date:3/22/2017)... STOCKHOLM , March 22, 2017 ... biopharmaceutical company developing novel anticancer therapies targeting the ... with Memorial Sloan Kettering Cancer Center to study ... p53 by APR-246. The goal of ... efficacy of APR-246 in combination with multiple other ...
(Date:3/22/2017)... Research and Markets has announced the addition of the "Global ... ... market to grow at a CAGR of 14.58% during the period ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
Breaking Medicine Technology:
(Date:3/22/2017)... ... March 22, 2017 , ... ... leading digital and print media enterprise focused on cancer patients, cancer centers and ... released a special 12-part educational video series, “No Ifs, Ands, or Butts,” that ...
(Date:3/22/2017)... ... 22, 2017 , ... The Rett Syndrome Research Trust (RSRT) ... that afflicts 350,000 individuals worldwide. Rett Syndrome is caused by alterations in ... females. Following a normal infancy, Rett Syndrome takes effect in toddlerhood depriving ...
(Date:3/22/2017)... , ... March 22, 2017 , ... ... to its Department of Orthopedic Surgery, Division of Hand, Upper Extremity and Microvascular ... surgery. She is board-certified in both Orthopedics and Hand Surgery. , ...
(Date:3/22/2017)... ... March 22, 2017 , ... Intrinsic Imaging, ... therapeutic experience and operational excellence in oncology clinical trials, proudly announces today that ... treatment of non-small cell lung cancer and small cell lung cancer. , Throughout ...
(Date:3/22/2017)... Norwich, NY (PRWEB) , ... March 22, 2017 , ... ... to communities in the greater Nassau County region, is embarking on a combined charity ... breast cancer. , For the last 25 years, the Great Neck Breast Cancer ...
Breaking Medicine News(10 mins):